- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06386367
Health Education by Buddhist Monks to Promote Malaria Knowledge and Preventive Practices in Rural Myanmar
April 25, 2024 updated by: Pyae Linn Aung, Myanmar Health Network Organization
Monastery-based Health Education by Buddhist Monks to Promote Malaria Knowledge and Preventive Practices in Rural Myanmar: A Quasi-experimental Study
Malaria is still a leading public health concern in Myanmar.
However, people living in rural areas usually showed poor prevention practice despite residing in malaria hotspots.
The majority in Myanmar are Buddhists who frequently visit the monastery and receive the speech delivered by the monks.
In a malaria high burden township of the Sagaing Region from northern Myanmar, current study will first explore the difference in malaria preventive practices among people residing in different malaria-endemic villages through a mixed-methods approach.
Next, this research will address the knowledge gaps by a monastery-based health education delivered by trained Buddhist monks using standardized health messages instruction for six consecutive months between August 2022 to January 2023.
To test whether the intervention could balance those gaps among different groups, quantitative data of baseline, 3-month, and 6-month will be compared using descriptive statistics, chi-square test, T-test or repeated ANOVA, and the Difference-In-Differences (DID) analysis, as applicable.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
501
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Yangon, Myanmar, 11091
- Myanmar Health Network Organization
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
For educational intervention; - voluntary participation
For questionnaire surveys;
- male or female household leaders or immediate family members
- aged >18 years who had resided in the study villages for more than one year
Exclusion Criteria:
For questionnaire surveys;
- Individuals who were unable to communicate effectively or were under the influence of narcotics, including alcohol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
Participants in the control group just received routine malaria control services such as diagnostic, treatment and bed net distribution.
|
|
Experimental: Monastery-based health education intervention
The education sessions were conducted in Burmese by trained monks.
They followed the normal teachings of the Buddhist doctrine and typically lasted 30-40 minutes.
Our research utilized Burmese as the medium for delivering health messages, and all accompanying materials were meticulously prepared in Burmese.
The study team observed at least one to two education sessions in each study village.
|
During the three-month intervention from July to September 2022, a total of 18 health education sessions were conducted across the three intervention villages, with an average of 50 attendees per session, totaling 921 attendees across all sessions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Malaria knowledge and preventive practices
Time Frame: Pre intervention (July 2022), 3-month post-intervention (Dec 2022) and 6-month post-intervention (Mar 2023)
|
To assess pre-existing malaria knowledge and preventive practices among both intervention and control groups, pre-intervention surveys were conducted.
Subsequently, three- and six-month post-intervention surveys were conducted to evaluate changes following the intervention.
A validated questionnaire translated from English to Burmese was used.
The questionnaire comprised three sections: demographic information of the respondents, knowledge of malaria and preventive practices.
Each section had multiple small questions, and each correct answer was scored.
The resultant scores were aggregated, wherein every participant had the potential to accrue a maximum of ten points pertaining to the attribution of malaria causation, symptoms of malaria, and adoption of personal preventative measures against malaria.
The participants were eligible to secure eight points in the domain of malaria diagnosis and treatment, alongside twelve scores for the use of LLINs.
|
Pre intervention (July 2022), 3-month post-intervention (Dec 2022) and 6-month post-intervention (Mar 2023)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2022
Primary Completion (Actual)
March 31, 2023
Study Completion (Actual)
March 30, 2024
Study Registration Dates
First Submitted
April 23, 2024
First Submitted That Met QC Criteria
April 23, 2024
First Posted (Actual)
April 26, 2024
Study Record Updates
Last Update Posted (Actual)
April 29, 2024
Last Update Submitted That Met QC Criteria
April 25, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MHNO-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malaria
-
University of California, San FranciscoCenters for Disease Control and Prevention; University of Massachusetts, Amherst and other collaboratorsRecruitingPlasmodium Falciparum Malaria | Plasmodium Vivax MalariaLao People's Democratic Republic
-
University of OxfordWellcome Trust; Ministry of public Health AfghanistanCompletedVivax Malaria | Uncomplicated Falciparum MalariaAfghanistan
-
Menzies School of Health ResearchInternational Centre for Diarrhoeal Disease Research, Bangladesh; Addis Ababa... and other collaboratorsCompletedMalaria | Vivax Malaria | Falciparum MalariaEthiopia, Bangladesh, Indonesia
-
Medicines for Malaria VentureAsociacion Civil Selva AmazonicaCompletedPlasmodium Falciparum Malaria | Plasmodium Vivax MalariaPeru
-
Gadjah Mada UniversityMenzies School of Health Research; Eijkman Institute for Molecular Biology; Timika...Completed
-
Menzies School of Health ResearchNational Health and Medical Research Council, Australia; Wellcome Trust; National...CompletedVivax Malaria | Falciparum MalariaIndonesia
-
London School of Hygiene and Tropical MedicineWorld Health Organization; United Nations High Commissioner for Refugees; HealthNet... and other collaboratorsCompletedMalaria | Vivax Malaria | Falciparum MalariaPakistan
-
Menzies School of Health ResearchNational Health and Medical Research Council, Australia; Wellcome Trust; National...CompletedVivax Malaria | Falciparum MalariaIndonesia
-
University of IbadanShin Poong Pharm Co Ltd 161 yoksam-ro, Gangnam-Gu Seoul 135-925, Korea; Institute...CompletedPlasmodium Falciparum Malaria | Uncomplicated Malaria | Malaria FeverNigeria
-
Research Institute for Tropical Medicine, PhilippinesWorld Health OrganizationCompletedTES of Artemether-lumefantrine for Pf and Chloroquine for Pv in the Philippines From 2013-2014 (TES)Malaria | Vivax Malaria | Falciparum Malaria | Malaria Recrudescence
Clinical Trials on Monastery-based health education by Buddhist monks
-
Tata Memorial HospitalUnknown
-
Tianjin HospitalCompletedLumbar Disc HerniationChina
-
Lihua XuCompletedCardiovascular DiseasesChina
-
Karamanoğlu Mehmetbey UniversityKaradeniz Technical UniversityNot yet recruiting
-
Pemba Ministry of Health ZanzibarActive, not recruitingHealth Education | SchistosomiasisTanzania
-
Ayşegül AkcaThe Scientific and Technological Research Council of TurkeyCompleted
-
VA Office of Research and DevelopmentCompletedCoronary Artery Disease | Stroke | Cardiovascular Disease | Psychological StressUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI); MedStar Georgetown University HospitalActive, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States, Canada
-
Ankara Yildirim Beyazıt UniversityNot yet recruitingLevel of Digital Game Addiction | Level of CyberbullyingTurkey
-
Bheri Zonal Ayurveda HospitalCompleted